Succeed with Sirion – Vaccine Strategy

videosSIRION Biotech GmbH
December 2nd 2021

Lasse Neukirch  and colleagues, including Christian Thirion, Dr., CEO and Founder of SIRION Biotech, developed a vaccine strategy that could represent a novel tool to successfully target diverse ERV-bearing tumors in patients with cancer. The vaccine strategy led them to find that T cell responses were strong enough to prevent colorectal CT26 tumor growth and progression in BALB/c mice after a single vaccination before or after tumor challenge. Read the full paper here:

Succeed with Sirion

LentiBOOST® - Lentiviral Transduction Enhancer For Clinical Applications